ASTRO 2022 | Future developments in cervical cancer treatment
Jyoti Mayadev
• 21 Oct 2022
Jyoti Mayadev, MD, University of California San Diego Medical Center, San Diego, CA, highlights the need for improved treatments for high-risk cervical cancer patients, including developments in immunotherapy and chemoradiotherapy. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consulting with Astra Zeneca
